Skip to main content
logo
Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
7.91
+0.18 (2.33%)
Nov 25, 2025, 2:58 PM EST - Market open

Myriad Genetics Revenue

Myriad Genetics had revenue of $205.70M in the quarter ending September 30, 2025, a decrease of -3.56%. This brings the company's revenue in the last twelve months to $825.30M, up 0.21% year-over-year. In the year 2024, Myriad Genetics had annual revenue of $837.60M with 11.21% growth.

Revenue (ttm)
$825.30M
Revenue Growth
+0.21%
P/S Ratio
0.86
Revenue / Employee
$305,667
Employees
2,700
Market Cap
737.32M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024837.60M84.40M11.21%
Dec 31, 2023753.20M74.80M11.03%
Dec 31, 2022678.40M-12.20M-1.77%
Dec 31, 2021690.60M133.60M23.99%
Dec 31, 2020557.00M-81.60M-12.78%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings

MYGN News

More News